Two committees oversee clinical research within UCLA's Jonsson Comprehensive Cancer Center (JCCC): the Internal Scientific Peer Review Committee (ISPRC) and Data Safety Monitoring Board (DSMB).
The Internal Scientific Peer Review Committee reviews clinical oncology protocols conducted by JCCC investigators. Drs. John Glaspy and Albert Lai serve as Co-Chairmen of the ISPRC. Under their direction, the committee reviews the required elements of the clinical protocol, statistical applications and other factors such as adequate research staffing, any competing trials, well-constituted data collection forms and utilization of other JCCC resources.
ISPRC application forms are available for download below. Please note that only electronic submissions will be accepted beginning July 1, 2011. Beginning July 17, 2012, the ISPRC submission deadline will be Tuesday at 5:00 PM.
ISPRC meetings are held every Tuesday. The deadline for submissions is every Tuesday at 5:00PM for the following Tuesday’s meeting.
In response to the National Cancer Institute mandate, the JCCC DSMB was constituted in January 2001 and meets monthly. The JCCC DSMB reviews all Serious Adverse Events (SAEs) occurring in JCCC protocols. In addition, the JCCC DSMB serves as the DSMB for institutional research studies at UCLA that do not have an external DSMB. The JCCC DSMB helps to ensure that adequate safety monitoring will be carried out for all cancer interventional trials offered at the JCCC. The DSMB oversees the implementation of the data monitoring plans approved by ISPRC and on file with the JCCC. The chairman of the JCCC DSMB is Dr. Sven De Vos.
JCCC has had a long-standing internal quality assurance program, beginning in 1986, to ensure proper conduct of clinical trials in oncology and, in so doing, safeguarding the rights and welfare of the study subjects. The internal compliance program is responsible for establishing an effective mechanism to promote proper adherence to all applicable local, state and federal laws, as well as specific program or cooperative group requirements by all researchers involved in oncology clinical research. The IQAP includes:
- Performance of prospective monitoring and retrospective auditing of active trials to ensure regulatory and protocol compliance
- Ensuring proper patient management per protocol and to ensure patient safety
- Assisting principal investigators, sub-investigators and all clinical trial study team members by consulting on problems identified during any monitoring or auditing reviews
- Educating and continually updating the research community regarding clinical research requirements
Please submit all applications to the Office of Regulatory Compliance via email: email@example.com
Please note that only electronic ISPRC submissions will be accepted beginning July 1, 2011.
Office of Regulatory Compliance
1001 Gayley Avenue
Suite 200, Room 13
Los Angeles, CA 90024
Mail Code: 735207
- Main Office: (310) 794-8742
Fax: (310) 794-8772
- Terra Hughes, M.S., Administrative Director
- Sujna Raval-Fernandes, Ph.D., Clinical Research Compliance Officer
- Uma Ganapati, Ph.D., Regulatory Affairs Reporting Coordinator
- Mark Glover, Admin. Specialist